Accelerate Your Data with Our Co-located Clinic and Lab
Ensuring Chain of Custody from Clinic to Lab
Did you know that our Canadian clinical facility is only a 15-minute drive from our bioanalytical facility?
This two-minute video provides an overview of our workflows, optimized to ensure timely collection, processing, transport, and rapid analysis of your samples for expedited go/no-go decision-making. Altasciences’ highly trained clinical staff and lab analysts understand the time-sensitive nature of your projects. Real-time access to essential data is our top priority.
Speak with one of our experts to learn more about our solution and how we can support your program.
Altasciences transforms the traditional outsourcing paradigm by simplifying and streamlining drug development solutions, whether for a single study or multiple programs, to offer an integrated/synchronized approach to CRO and CDMO services.
Have five minutes? Take a look at these:
Scratching the Surface of Dermal Testing
Avoid These Mistakes During Formulation for Nonclinical Testing
Improve Your Odds of Success
Formulation development is a critical step that ensures the drug product is produced safely and effectively for use in nonclinical testing and, eventually, in clinical trials. Solubility, stability, route of administration, and dosage frequency are some of the factors assessed during formulation development.
In this podcast, our scientific experts discuss the everyday challenges encountered in formulation development for nonclinical testing, and tips to avoid or mitigate them to facilitate your IND application.
Do you need your API formulated and manufactured for nonclinical testing? Contact us today to get started!
Related Resources:
- Webpage: Contract Manufacturing and Analytical Solutions
- Interview: Complex and Customized Formulation Development
- Podcast: Key Considerations as You Move From Discovery to Preclinical to Clinical
Altasciences transforms the traditional outsourcing paradigm by simplifying and streamlining drug development solutions, whether for a single study or multiple programs, to offer an integrated/synchronized approach to CRO and CDMO services from lead candidate selection to clinical proof of concept, and beyond.
Dr. Keyhani Reflects on International Day of Women and Girls in Science
Opinion | A Day to Celebrate, and a Call to Action
Dr.
Case Study―Evaluating Milling Conditions for Scaling Up a Nanosuspension Drug Product
Benefits of Increasing Automation in the Lab
In this webinar, learn about the extent of automation within bioanalysis in today’s landscape, the practicality of automated technologies for extraction methods and ligand binding assays, and future projections for bioanalytical automation.
Speak with an expert about your research needs.
You may also be interested in the following:
- Webpage: Bioanalytical Platforms
- The Altascientist: The Evolution and Advancement of LC-MS in Drug Development
A Leading Partner in Ophthalmic Drug Development
Comprehensive Ophthalmic Drug Development Solutions
As an industry leader in ophthalmic drug development and research, our integrated CRO/CDMO solutions allow you to work with a single partner as your ocular compound advances from prototype formulation to preclinical testing through to early phase clinical trials and manufacturing.
Discover how Altasciences' end-to-end ophthalmic drug development solutions can help reduce your timelines by up to 40%!
Have questions? Consult with one of our experts.
You may also be interested in: